Ian Nessler
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 5
- CAR-T cell therapy research 5
-
- Monoclonal and Polyclonal Antibodies Research 8
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Greg M. Thurber (9 shared papers)Cornelius Cilliers (4 shared papers)Jennifer J. Linderman (1 shared paper)Eshita Khera (3 shared papers)Adnan O. Abu‐Yousif (2 shared papers)Thomas A. Keating (2 shared papers)James Legg (1 shared paper)Qifeng Qiu (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Neoplasia (1 paper)Journal of Nuclear Medicine (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Ian Nessler
12 papers receiving 376 citations
Peers
Comparison fields: 5 of 53
- Radiology, Nuclear Medicine and Imaging 238
- Oncology 220
- Immunology 40
- Molecular Biology 125
- Biomaterials 22
Countries citing papers authored by Ian Nessler
This map shows the geographic impact of Ian Nessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Nessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Nessler more than expected).
Fields of papers citing papers by Ian Nessler
This network shows the impact of papers produced by Ian Nessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Nessler. The network helps show where Ian Nessler may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Nessler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 90 | |
| 2 | 2020 | 87 | |
| 3 | 2017 | 84 | |
| 4 | 2020 | 39 | |
| 5 | 2021 | 21 | |
| 6 | 2014 | 18 | |
| 7 | 2019 | 13 | |
| 8 | 2016 | 11 | |
| 9 | 2022 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2020 | 6 | |
| 12 | 2024 | 3 |
About Ian Nessler
Ian Nessler is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, Physical and Theoretical Chemistry and Organic Chemistry, having authored 12 papers that have together received 385 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), HER2/EGFR in Cancer Research (5 papers), CAR-T cell therapy research (5 papers), Crystallography and molecular interactions (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Pancreatic function and diabetes (1 paper), Chemical Thermodynamics and Molecular Structure (1 paper) and Cell Image Analysis Techniques (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (238 citations), Oncology (220 citations), Immunology (40 citations), Molecular Biology (125 citations) and Biomaterials (22 citations). Ian Nessler has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Greg M. Thurber, Cornelius Cilliers, Jennifer J. Linderman, Eshita Khera, Adnan O. Abu‐Yousif, Thomas A. Keating, James Legg, Qifeng Qiu, Thomas Sandal and Michael J. Schnieders. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Neoplasia, Journal of Nuclear Medicine and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.